Rang	Name	Position
1	Dr. Joseph K. Belanoff M.D.	Co-Founder, President, CEO & Director
2	Mr. Atabak Mokari	CFO & Treasurer
3	Mr. Sean Maduck	President of Endocrinology
4	Dr. William Guyer Pharm.D.	Chief Development Officer
5	Mr. Gary Charles Robb J.D.	Chief Business Officer & Secretary
6	Mr. Joseph Douglas Lyon	Chief Technology & Accounting Officer
7	Dr. Hazel Hunt Ph.D.	Chief Scientific Officer
8	Ms. Amy Flood	Chief Human Resources & Communications Officer
9	Ms. Monica Tellado	President of Emerging Markets
10	Mr. Roberto W. Vieira	President of Oncology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,24%	1,37 Mrd. USD
2	Ingalls & Snyder LLC	7,04%	0,86 Mrd. USD
3	Renaissance Technologies Corp	5,26%	0,64 Mrd. USD
4	Vanguard Portfolio Management, LLC	4,46%	0,54 Mrd. USD
5	Vanguard Capital Management, LLC	3,77%	0,46 Mrd. USD
6	Parallel Advisors, LLC	3,68%	0,45 Mrd. USD
7	State Street Corp	2,96%	0,36 Mrd. USD
8	FMR Inc	2,95%	0,36 Mrd. USD
9	Geode Capital Management, LLC	2,51%	0,31 Mrd. USD
10	First Trust Advisors L.P.	1,69%	0,21 Mrd. USD
11	TANG CAPITAL MANAGEMENT LLC	1,39%	0,17 Mrd. USD
12	UBS Group AG	1,26%	0,15 Mrd. USD
13	Dimensional Fund Advisors, Inc.	1,22%	0,15 Mrd. USD
14	Charles Schwab Investment Management Inc	1,04%	0,13 Mrd. USD
15	Morgan Stanley - Brokerage Accounts	0,94%	0,12 Mrd. USD
16	D. E. Shaw & Co LP	0,82%	0,10 Mrd. USD
17	MPM Oncology Impact Management LP	0,71%	0,09 Mrd. USD
18	Emerald Advisers, LLC	0,69%	0,08 Mrd. USD
19	HPM Partners LLC	0,68%	0,08 Mrd. USD
20	The Goldman Sachs Group Inc	0,67%	0,08 Mrd. USD